Blast at Pharma Plant in Telangana Claims One Life, Injures Seven
One killed, seven injured after blast in pharma plant in Telangana
News 18
Image: News 18
A reactor explosion at a pharmaceutical plant in Nalgonda district, Telangana, resulted in one death and seven injuries. The incident occurred on May 1, with victims receiving treatment in Hyderabad. The cause of the explosion remains under investigation.
- 01One person died and seven were injured in a blast at a pharma plant in Nalgonda, Telangana.
- 02The explosion occurred on May 1 during work hours, affecting ten employees.
- 03Injured individuals were transported to a super-speciality hospital in Hyderabad for treatment.
- 04The deceased reportedly jumped from the second floor to escape the blast.
- 05This incident follows a previous fire accident at the same plant in April.
Advertisement
In-Article Ad
On May 1, a reactor explosion at a pharmaceutical plant in Nalgonda district, Telangana, led to the death of one worker and injuries to seven others. The blast occurred in the afternoon on the first floor of the two-storey facility, where ten employees were present. Following the explosion, six injured workers were transferred to a super-speciality hospital in Hyderabad for advanced medical care. Tragically, one of the injured succumbed to his injuries, believed to have been sustained after he jumped from the second floor to escape the blast. The remaining injured individuals are reported to be in stable condition. Authorities are currently investigating the cause of the explosion. Notably, this incident follows a fire accident at the same plant in April, which resulted in injuries to two workers, both of whom have since recovered.
Advertisement
In-Article Ad
The explosion raises concerns about safety protocols in local pharmaceutical manufacturing facilities, potentially affecting worker safety regulations.
Advertisement
In-Article Ad
Reader Poll
How should the government improve safety in industrial workplaces?
Connecting to poll...
Read the original article
Visit the source for the complete story.



